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Abstract
Cellular signal transduction machinery integrates information from multiple inputs to actuate discrete
cellular behaviors. Interaction complexity exists when an input modulates the output behavior that
results from other inputs. To address whether this machinery is iteratively complex, that is, whether
increasing numbers of inputs produce exponential increases in discrete cellular behaviors, we
examined the modulated secretion of six cytokines from macrophages in response to up to 5-way
combinations of an agonist of Toll-like receptor 4 with 3 cytokines and the cyclic adenosine
monophosphate pathway. Although all of the selected ligands demonstrated synergy in paired
combinations, few examples of nonadditive outputs were found in response to higher-order
combinations. This suggests that most potential interactions are not realized and that unique cellular
responses are limited to discrete subsets of ligands and pathways that enhance specific cellular
functions.
INTRODUCTION
The outcomes of signal transduction pathways are usually ascertained by studying the effects
of specific, single ligands on isolated cells in culture; however, cells are rarely exposed to a
single stimulus in vivo, and cellular behavior can be highly dependent on the integration of
responses to a combination of specific stimuli and on the context in which they occur. This is
clearly evident in the immune system. During the response to infection, the interaction of viral
or bacterial components with T helper (TH) cells and macrophages causes the production of
cytokines and chemokines, which in turn form a network of chemoattractants and activators
for circulating leukocytes in vivo. The nature of an inflammatory response is determined by
the primary signaling pathways evoked and by interactions among these pathways. For
example, the production of cytokines in response to initiators of inflammation can be influenced
by synergy between individual Toll-like receptors (TLRs). Mice treated with TLR agonists
that stimulate myeloid differentiation marker 88 (MyD88)-dependent pathways in combination
with those TLR agonists that activate MyD88-independent pathways produce elevated,
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nonadditive concentrations of tumor necrosis factor α (TNF-α), macrophage inflammatory
protein-1α (MIP-1α), and interleukin 6 (IL-6) in their serum compared to the predicted
secretion of the cytokines based on mice treated with each TLR agonist individually1.
Environmental factors and secondary responses also modulate output. Thus, production of
chemoattractants is often strongly regulated by synergy between secreted cytokines2. For
example, intra-articular injection of submaximal doses of TNF-α and IL-1 into the knees of
rabbits results in a nonadditive increase in the numbers of polymorphonuclear cells in the
synovial lining as compared to that elicited by either cytokine alone, which provides evidence
for a biological role of synergy in cell recruitment3, 4.
Regulation of signal transduction through synergy or anergy among pathways provides a
simple and plausible mechanism to dramatically change the nature of downstream responses
to a stimulus depending on the presence of other relevant stimuli. From an experimental
standpoint, these signaling regimes are unique in that they are not inherently predictable from
their individual components. The first step in elucidating such synergies is a profiling approach,
which may also provide the initial insight needed for the mechanistic deconstruction of the
signaling architecture in the cells of interest and the manner in which such signaling is
mediated. For example, elucidation of cytokine secretion profiles in response to multiple,
simultaneous stimuli and knowledge of their input-output relationships can be a precursor to
understanding complex physiological processes mediated by macrophages.
Initial profiling of crosstalk between signal transduction pathways in a macrophage-like cell
line (RAW 264.7) by the Alliance for Cellular Signaling (AfCS) included quantification of
cytokines secreted in response to stimulation by 22 individual ligands and by all 231 pair-wise
combinations5. Global analysis of this dual ligand screen revealed both known and novel
synergistic interactions between these ligands. For example, these nonadditive, synergistic
effects could result in 20- to 40-fold increases in the output of a given second messenger and
they reflected novel patterns of pathway interactions for subsequent elucidation6, 7. However,
approximately 90% of the pairwise combinations of ligands resulted in predictable additive
responses. This suggests that only a small discrete number of the many possible interactions
between signaling pathways are selected and actuated, whereas the vast majority of possible
interactions are unrealized or ineffective.
An essential question that follows is whether the same pattern will hold in a biologically
relevant process with responses to higher-order combinations of ligands. Thus, will only a
small subset of combinations lead to nonadditive, unique responses or will increased
complexity of inputs produce exponential increases in discrete cellular behaviors? As with dual
ligand stimulations, the potential for synergies among multiple pathways makes simple
extrapolation from the dual ligand instance insufficient; direct testing is required. Because the
testing of higher-order combinations of ligands increases exponentially the number of
experiments to be performed, a subset of stimuli and outputs were chosen from the dual ligand
screen to identify additional interactions in response to 3-, 4-, and 5-way combinations of
ligands.
Lipopolysaccharide (LPS) and its receptor TLR4 are thought to be crucial arbiters of sepsis.
Observations that mice devoid of TLR4 or its associated protein MD-2 are hyporesponsive to
LPS8, 9 and resistant to endotoxic shock10 emphasize the biological importance of this
receptor complex in vivo. We chose to profile modulation of the cytokine responses of RAW
264.7 cells to stimulation of TLR4, the best characterized receptor of the TLR family11–14,
by four ligands: interferon-β (IFN-β), transforming growth factor β-1 (TGF-β), IL-6, and
isoproterenol (ISO) or a nonhydrolyzable analog of its second messenger, 8-Bromo-cAMP
(8Br). Similarly, the outputs measured were limited to 4 cytokines, granulocyte colony–
stimulating factor (G-CSF), IL-6, IL-10, and TNF-α and 2 members of the cysteine-cysteine
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(CC) family of chemokines, MIP-1α and regulated upon activation, normal T cell expressed
and secreted (RANTES), which were readily detectable in secretions from RAW 264.7 cells.
Higher-order synergies between the ligands tested were elucidated through a new approach to
determine statistical significance in multifactorial experiments based on established
methodologies.
Two major sets of findings were revealed through the analysis of this data set. The first relates
to the architecture of signaling networks for generating unique signaling regimes. Despite the
fact that almost all of the pairs of ligands used were capable of nonadditive interactions that
caused unique signaling regimes, only a modest subset of higher-order combinations resulted
in unique paradigms of secretion of individual cytokines. The inference to be made from these
data is that complex nonlinear interactions are limited in these signaling networks despite the
multitude of possibilities. Second, our analysis comprehensively documented that discrete
combinations of a TLR agonist, IFN-β, ISO or 8Br, and TGF-β could simultaneously regulate
multiple cytokines through parallel mechanisms and provide a basis for future elucidation of
novel pathways and modeling of specific context-dependent behaviors.
RESULTS
Profiles of ligand-induced cytokine secretion by RAW 264.7 cells
Secretion of IL-10, IL-6, RANTES, MIP-1α, G-CSF, and TNF-α was examined after cells were
stimulated through TLR4 with a chemically defined LPS, 3-deoxy-D-manno-octulosonic acid
(KDO)2-Lipid A15, 16, in all possible combinations with the ligands ISO (or 8Br), TGF-β,
IL-6, or IFN-β. All of the cytokines and chemokines measured in this study were readily
secreted by RAW 264.7 cells in response to KDO (Fig. 1), which was chosen as the stimulus
instead of LPS to reduce variability in measurements.
IFN-β also induced the production of IL-6, IL-10, MIP-1α, RANTES, and TNF-α, and IL-6
induced the production of IL-10. Although TGF-β and ISO did not have any measurable effects
on cytokine release individually during this time course (Fig. 1), they were included because
of their substantial modulation of cytokine secretion induced by TLRs5. As will be shown, the
combination of ISO, 8Br, TGF-β, IL-6, or IFN-β with KDO potentiated or inhibited the
secretion of multiple cytokines induced by KDO, data that are consistent with previously
published findings that show crosstalk between LPS and a subset of biologically diverse ligands
that regulate the secretion of cytokines5. These studies are extended here to examine the extent
of crosstalk among pathways, that is, to determine what higher-order interactions could be
observed when cells were stimulated with KDO and multiple combinations of the interacting
ligands.
Evaluation of interactions among multiple ligands
Interactions between cytokines were quantified through an approach similar to previous
methodologies5 wherein a z-score-like parameter estimated the difference between the
expected outcome and the observed outcome as weighted by the propagated errors (see
Materials and Methods). Note that a nonadditive response to two or more ligands simply
indicates that the downstream signal transduction pathways share a signaling component; the
mechanism of how the interaction occurs is not revealed. The z-score parameter simply
quantifies the significance of nonadditivity in the positive (synergy) or negative (antagonism)
direction.
A graphic illustration shows how different signaling regimes are possible (Fig. 2). The
combination of two ligands with the cytokine responses L1 and L2 can elicit: (i) significant
synergy—a response greater than the sum of both responses (>L1+L2), indicated by the region
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in red; (ii) significant inhibition—a response less than the least response to any individual
ligand as indicated by the region in blue, that is <L1 (an exception occurs when L1 or L2 has
no effect alone, in which case any significant decrease is clear inhibition); (iii) additivity—a
response that is not significantly different from the additive sum of all the responses, indicated
by the region in white around the dotted line that represents the sum of all responses (~L1+L2).
In addition to these simple cases, there is also a region that is below additivity but above
inhibition (that is, L1+L2 > response > L1) that may be a result of any one of several factors,
such as partial inhibition, saturation of a signaling component, antagonism or competition, for
example (shaded in a range from light yellow to dark green). With the inclusion of more ligands
in the experiment, the predicted additivity is not simply the sum of the responses to individual
ligands but also includes nonadditive contributions between them. For example, for 4-way
combinations, the nonadditive contributions of all 2-way and 3-way combinations in addition
to the responses to the four individual ligand treatments are factored in (see Methods and
Materials).
More complex scenarios are likely to exist with the larger combinations of ligands examined
in this study. For instance, in the event that some ligands are excitatory whereas other ligands
are inhibitory, the addition of another ligand could relieve the net inhibition, which is
numerically calculated as a positive z-score, yet the final amount of cytokine that is secreted
in response to the combination may be much smaller than some of the responses to individual
ligands. Extensive experimentation is likely necessary to decipher the mechanisms of action
in all such cases. We have characterized all signaling outcomes with the above coloring scheme
to provide an easy visual method of identifying significant changes. Note that a z-score does
not have a one-to-one relationship with color intensity for less-than-additive values. If the
observed value is lower than the least response to any individual ligand or to an n-1 subset of
combinations, we can then clearly classify the response as inhibitory and its significance is
coded in blue. For all other less-than-additive cases, we cannot distinguish between inhibition,
saturation, or competition without further experimentation. Therefore these are explicitly
color-coded yellow-green. Thus, the actual color code in the less-than-additive responses is
not dependent purely upon the magnitude of the z-score (significance of difference), but is also
dependent upon the least response within each experiment and is thus relative. Thus, it is
possible to have a scenario in which a large negative z-score may be colored green in one
experiment whereas a smaller negative z-score may be colored blue in a different experiment.
A cumulative summary of responses is presented in the final figure for easy comparison across
combinations and for use by the signaling community at large. We describe and characterize
some of the strong synergistic and inhibitory responses in this study below.
Examples of complex signaling regimes induced by stimulation with multicombinatorial
ligands
Examples of nonadditivity between ligands on the secretion of IL-10 are first discussed (Fig.
3). Individually, IFN-β, IL-6, and KDO induced the secretion of IL-10 from RAW 264.7 cells
(Fig. 1, Fig. 3, A and B). When either IFN-β or IL-6 was combined with KDO and added
simultaneously to RAW 264.7 cells, the expected secretion of IL-10 (the additive sum of
responses from stimulation with each ligand alone) was far less than the experimentally
observed responses to the combinations (Fig. 3, A and B). The dramatic increase in the amount
of IL-10 secreted suggests that IFN-β and IL-6 can cooperatively interact with KDO to regulate
the secretion of IL-10. The large synergies with the dual ligands were partially blunted when
all three ligands were applied to the cells. Thus, the observed effect was significantly less than
the additive prediction (Fig. 3D) and saturation of common elements in the pathway or an
antagonism between IL-6 and IFN-β is likely. An interesting hypothesis derives from the
observation that the combination of KDO and IFN-β also synergistically induced the secretion
of IL-6 (Fig. 3C).
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The latter result suggests the hypothesis that synergistic production of IL-6 by KDO and IFN-
β may have acted in an autocrine feedback loop to contribute to the observed synergistic
increase in the secretion of IL-10 evoked by KDO and IFN-β. If so, the three-way combination
of KDO, IFN-β, and IL-6 must have resulted in a less-than-additive response, because any
synergy from the combination of KDO and IL-6 would already be represented, at least in part,
from the IL-6 produced by the combination of KDO and IFN-β. This would most likely be
observed as a time-dependent decrease in synergy or loss of additivity as IL-6 accumulated in
the assay. A clear trend to support this was not observed (Fig 3D). In order to assess whether
secreted IL-6 was playing a substantial role, the secretion of IL-10 was examined at different
doses of IL-6. The threshold concentration of IL-6 required for stimulating the secretion of
IL-10 was 0.2 nM (> 4 ng/ml, a concentration above the maximal 2 ng/ml of IL-6 produced
by the stimulating conditions at 4 hr. Whereas it is possible that the secreted IL-6 might have
been more effective than that added in bulk to initiate incubations, it is probable that the large
synergy in secretion of IL-10 seen with KDO and IFN-β and the less than additive response
seen with the combination of KDO, IFN-β and IL-6, were not due to an autocrine effect of
secreted IL-6 (see Discussion).
In the instance where nonadditive responses to two or more combinations of ligands are
mediated through completely independent mechanisms, a multifactorial combination of these
same ligands should yield additive responses. One such instance is now discussed (Fig. 4). ISO
and TGF-β independently inhibited the amount of MIP-1α secreted in response to KDO (Fig.
4, A and B). These results suggest that ISO and TGF-β each individually share a common
regulatory element with KDO in the regulation of the secretion of MIP-1α. However, the
essentially additive response to the triple ligand combination (σ < ±1, Fig. 4C) suggests that
although the combinations of KDO-ISO and KDO-TGF-β each share a common stimulating
component to regulate the secretion of MIP-1α, the two interaction elements and subsequent
pathways are probably different from each other. If this is the case, the data suggest that there
are at least two distinct mechanisms by which the secretion of MIP-1α can be regulated by
KDO.
Regulation of secretion of G-CSF by KDO, IFN-β, and cAMP pathways
Our multiligand screen has also identified previously uncharacterized interactions among
KDO, IFN-β, and cAMP pathways that simultaneously regulated the secretion of 3 cytokines.
Both ISO or 8Br and IFN-β regulated KDO-induced secretion of G-CSF, but in opposing
directions; cAMP, either stimulated by ISO or added directly as 8Br amplified KDO-dependent
secretion of G-CSF, whereas IFN-β modestly inhibited secretion of the cytokine. When cells
were treated with the combination of KDO, IFN-β, and ISO or KDO, IFN-β, and 8Br, secretion
of G-CSF was less than that of the additive prediction (Fig. 5, A and B). Indeed, IFN-β almost
eliminated the enhancement effected by ISO, although it was less dominant against the more
efficacious 8Br. These results suggest a shared mode of regulation for G-CSF among the three
pathways.
This interaction among the pathways was also observed in the relative abundance of G-CSF
messenger RNA (mRNA). The addition of ISO increased the abundance of G-CSF mRNA,
whereas the inclusion of IFN-β reduced the amount of G-CSF mRNA induced by KDO at early
times or by KDO and ISO at all times (Fig. 5C). The similarity in the pattern of expression of
G-CSF mRNA and the secretion of G-CSF protein indicates that the point at which these
pathways intersect is at, or upstream of, the production of mRNA. The data also suggest that
regulation of G-CSF production by these ligands is not dominated by a single pathway and
that responses will be dictated by the relative strength of the different stimuli.
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Regulation of MIP-1α secretion by KDO, IFN-β, and cAMP pathways
The second cytokine that was regulated by the combination of KDO, IFN-β, and cAMP
pathways was MIP-1α (Fig. 6). KDO and IFN-β individually induced increases in the
abundance of MIP-1α mRNA (Fig. 6C) and in the secretion of MIP-1α protein (Fig. 1). The
combination of KDO and IFN-β resulted in potentiated secretion of MIP-1α (Fig. 6), a result
that contrasted with the inhibitory effect of IFN-β on KDO-induced secretion of G-CSF (Fig.
5). ISO interacted with the KDO pathway to antagonize secretion of MIP-1α (Fig. 6), which
is also a contrast to its potentiation of G-CSF secretion by the TLR pathway. When IFN-β,
ISO, and KDO were simultaneously added to RAW 264.7 cells, the competing effects on the
secretion of MIP-1α were less than additive. This pattern of interaction among the three
pathways was further substantiated by the observations with 8Br, which maximally stimulated
the cAMP pathway (Fig. 6B). The less-than-additive effects obtained with ISO and IFN-β on
stimulating the secretion of MIP-1α by KDO may be explained by the inhibitory effects of ISO
on secretion of the cytokine induced by IFN-β alone5. Similar to G-CSF, regulation of
MIP-1α did not appear to be dominated by KDO, IFN-β, or the cAMP pathway.
Unlike that of G-CSF, changes in the secretion of MIP-1α did not mirror changes in the
abundance of its mRNA (Fig 6C). When KDO and ISO were combined, the abundance of
MIP-1α mRNA and the secretion of MIP-1α protein were both lower than with KDO alone.
However, the combination of KDO and IFN-β produced less than or additive effects on the
abundance of MIP-1α mRNA while potentiating secretion of the protein. This suggests that
the synergy between KDO and IFN-β in the regulation of MIP-1α secretion occurs through a
posttranscriptional regulatory mechanism. This complex regulation was further observed when
all three ligands were combined; the less-than-additive response in the secretion of the cytokine
was not accompanied by a significant reduction in the abundance of MIP-1α mRNA beyond
that observed when ISO alone was added with KDO. These observations likely represent
nonredundant mechanisms (transcriptional and posttranscriptional) of regulating the secretion
of MIP-1α by KDO and IFN-β because the observed synergy was not detected at the level of
transcription.
Potentiation of the secretion of IL-6, but not IL-10, by KDO, IFN-β, and cAMP pathways
Although the triple ligand combination resulted in intermediate quantities of secreted G-CSF
and MIP-1α, secretion of IL-6 was greatly potentiated when IFN-β, KDO, and the cAMP
pathway were combined (Fig. 7), which suggests that these pathways share common
mechanisms to simultaneously regulate secretion of this cytokine. Interestingly, IL-10, which
was secreted in response to IL-6, did not show similar potentiation (see Fig. 9). Presumably,
the amount of IL-6 secreted was insufficient to support an autocrine response, as discussed
earlier. Whereas the synergism of IFN-β and KDO observed for both IL-6 and IL-10 may share
a common mechanism, the data indicate that synergy of the cAMP pathway is achieved at a
branch unique to regulation of IL-6 and probably downstream from the interaction of IFN-β
and KDO.
TGF-β regulates secretion of IL-6 stimulated by the KDO, IFN-β, and cAMP pathways
TGF-β by itself had no measurable effect on the secretion of IL-6 from RAW 264.7 cells;
however, it attenuated the two-way synergistic combination of KDO and IFN-β (Fig 8).
Whereas TGF-β did not appear to attenuate the synergy between KDO and ISO, anergy was
observed when TGF-β was combined with the more efficacious combination of 8Br and KDO
(Fig. 7B, Fig. 8). This demonstrates that TGF-β strongly inhibited the synergistic responses of
these ligand pairs. Although the four-way combination with KDO, IFN-β, ISO, and TGF-β
was largely additive, the much larger synergy in IL-6 production by KDO, IFN-β and 8Br was
significantly attenuated by TGF-β beyond the additive attenuation expected (Fig. 8B). This
suggests that not only could TGF-β inhibit the synergistic stimulation of IL-6 by KDO and
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cAMP pathways or by KDO and IFN-β, it also suppressed the three-way synergy observed
with KDO, IFN-β and mobilization of cAMP-dependent pathways.
A systematic compilation of non-additivity across all combinations
As the calculation of nonadditivity by σ units is inherently dimensionless, it enables us to
compile, and therefore compare, responses to all combinations of ligands to determine the
extent of nonadditivity in response to all of the 2-, 3-, 4-, and 5-way combinations examined
in this study (Fig. 9). This approach allowed us to easily visualize the effects of compounding
nonadditive interactions from smaller combinations of ligands to higher-order combinations
—a tool whose value cannot be underestimated when compiling such complex datasets.
Secondly, this allows us to estimate the extent of nonadditivity with increases in input
complexity.
DISCUSSION
This study simultaneously examines the secretion of 6 factors (G-CSF, IL-6, IL-10, MIP-1α,
RANTES, and TNF-α) by RAW 264.7 cells in response to simultaneous application of multiple
stimuli. The multi-cytokine responses were used to examine two issues. As a platform to
identify instances of significant nonadditivity, the multi-factorial experiments addressed the
general question of complexity and crosstalk in signal transduction. This same profiling process
was used to identify previously uncharacterized and specific higher-order interactions that
regulated cytokine secretion. With regard to the first point, does greater information
complexity, in this case larger numbers of stimuli encountered by a cell, equate to greater
complexity in output? In other words, if a cell is capable of responding to a number of individual
stimuli that result in a unique set of behaviors, does presenting the total ensemble or various
subsets of inputs result in unique sets of responses? Moreover, does such behavior scale with
an increase in the number of inputs? The current literature presents contrasting possibilities.
High-throughput measurements of protein-protein interactions, such as those obtained through
two-hybrid experiments, and the large number of components now identified in cellular
signaling systems, lead to speculation that the networks of signal transduction machinery are
inordinately complex17, 18. However, such observations often reflect connections that are
possible in an in vitro context and are not necessarily of physiological consequence in vivo.
Other studies indicate that cells may have evolved elaborate mechanisms to limit interaction
complexity, and may have invested heavily in the macromolecular organization of signaling
machinery to limit both the spatial and temporal spreading of signaling events in cells19, 20.
The mechanisms that limit interactions are more difficult to define than those that encourage
synergy.
Our study examined this issue in a system in which a number of different factors are known
to interact in simple combinations of inputs, and thus allowed us to ask in a meaningful context
whether novel signaling regimes arise from complex higher-order combinations of elements.
Although our own work5 and other studies21–25 have profiled the extent and context-
dependence of nonadditive cellular responses to pairs of stimulators, this is the first study that
systematically examines whether complex signaling responses can be mediated in response to
stimulation by higher-order combinations of ligands. Importantly, the results show that such
higher-order combinations of ligands can induce unique signaling regimes, but that such
instances are limited when compared to the total number of combinations possible (~33%, with
the majority in the 3-way combinations). This limitation is considered important because all
of the ligands used in this study were known to be interactive through their production of
nonadditive responses in two-way combinations.
Although we cannot generalize signaling architectures from one set of results, the following
conclusions can be drawn in this instance. First, complexity of output responses is “encoded”
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or “hard-wired” into the system by the presence of interactions between pathways (as evinced
by the nonadditivity of the two-way combinations). Increasing the number of stimuli to engage
more of these interactions between pathways did not, in general, result in a concomitant,
iterative increase in output complexity. Second, the interactions that are realized can uniquely
shape overall cellular behavior in response to complex stimuli. Almost every higher-order
combination of ligands, (that is, looking at each row in Fig.9 for all combinations of ligands
3- or higher, 14/15 rows) did elicit a significant, nonadditive response in at least one cytokine;
however, nonadditive changes among individual cytokines are often not observed even though
certain pairs of ligands involved were highly interactive [see responses for MIP-1α and TNF-
α (Fig. 9)]. Because such unrealized interactions to ligand combinations varied with individual
cytokines, correlations in nonadditive responses among various cytokines observed with dual
ligands5 (Fig. 9, top panel) were not maintained with higher-order combinations of the same
ligands. Thus, higher-order combinations of ligands gave rise to limited, unique behaviors
based on restricted interactions among the signaling pathways.
The estimate of nonadditivity does not inform us about the mechanism by which it happens.
Although some cytokines appear to trend together in their responses to the two-ligand
perturbations, this does not imply a similarity in how this nonadditivity is mediated for these
cytokines. This becomes especially evident when the correlation is lost with higher-order
combinations of ligands. Indeed, this suggests that the mechanisms for the correlated behavior
with dual ligands are different. By comparing and contrasting responses across combinations
of ligands, we can gain some insight into the requirements for the nonadditivity observed, and
this will help shape future studies to elucidate the molecular mechanisms involved.
Thus, even in a multifactorial system such as the cytokine network in which multiple crosstalk
and feedback loops are present, information complexity is encoded in sparse and discrete
instances. This suggests that context-dependence, or the ability of the system to recognize two
stimuli in conjunction and to respond differently from either stimulus taken individually, is
encoded through select interactions or pathways that are not extensively or promiscuously
activated. Several other studies have argued that such limitation of interaction complexity is
evolved in architectures that enhance “robustness” or dependability of signal transduction19,
20. If this is true, it stands to reason that the few higher-order interactions observed are very
likely to indicate biologically important phenotypes.
A second objective of this study was to identify any novel higher-order interactions between
the signaling mechanisms downstream of the receptor for LPS (a major antigenic factor of
gram-negative bacteria) and the 4 families of receptors used. Although the molecular
mechanisms by which these pathways exert their effects cannot be definitively determined by
this approach, our data are highly consistent with published mechanisms that regulate cytokine
secretion (as outlined below) and allow for tractable generation of hypotheses for future
experimentation.
We focused specifically on the novel observation that the downstream pathways from IFN-β
and cAMP interacted to simultaneously both amplify and inhibit G-CSF and MIP-1α produced
in response to KDO. Furthermore, secretion of IL-6 was greatly potentiated when all three
ligands were combined. These data demonstrate the multiple regulatory nature of each pathway
to simultaneously and differentially modulate multiple cytokines as discussed below.
The secretion of many cytokines is regulated through de novo synthesis of their nascent
transcript. Stimulation of the secretion of G-CSF by KDO was inhibited by IFN-β, but was
potentiated by cAMP-dependent pathways. When all three ligands were combined, a less-than-
additive, intermediate amount of G-CSF was secreted. The relative pattern of secreted G-CSF
obtained with single, double, and triple combinations of ligands mirrored the pattern observed
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in the expression of its mRNA (Fig. 5), which suggests that these interacting pathways
regulated secretion of this cytokine by regulating the expression of its mRNA.
Regulation of MIP-1α by the same ligands showed opposing effects and suggests the existence
of additional mechanisms. Unlike its effect on secretion of G-CSF, cAMP-dependent pathways
suppressed secretion of MIP-1α induced by KDO and this was paralleled by attenuation of the
KDO-induced expression of MIP-1α mRNA (Fig. 6). This modulation of mRNA expression
for both cytokines indicates that the intersection between the TLR4 and cAMP pathways for
regulation of secretion either resides upstream of transcription or at the regulation of transcript
production or stability. One putative node of intersection could be in the regulation of nuclear
factor κB (NF-κB), a key mediator of the TLR-induced secretion of many cytokines; however,
the opposing action of cAMP on G-CSF and MIP-1α indicates that this cannot uniquely account
for both effects.
In contrast to G-CSF, the greater-than-additive amounts of MIP-1α secreted in the presence of
KDO and IFN-β was accomplished while the abundance of MIP-1α mRNA either did not
change or showed a less-than-additive response. This result has also been observed in purified
human monocytes cultured with IFN-α and LPS26. Thus, regulation by IFN-β appears to occur
through two pathways. Stimulation of MIP-1α secretion by IFN-β alone correlated with a
modest increase in the abundance of MIP-1α mRNA and predicts a transcriptional mechanism
of regulation. However, a lack of increased abundance of mRNA in contrast to the greater-
than-additive secretion obtained with the combination of IFN-β and KDO predicts an additional
mechanism that is not transcriptional in nature, such as an increase in the rate of translation,
trafficking through secretory vesicles, or both. Whereas regulation of the secretory pathway
for newly synthesized cytokines, such as MIP-1α, is not well understood, potential mechanisms
are suggested by regulation of the secretion of TNF-α. Recent evidence suggests roles for
vesicle-associated membrane protein 3 (VAMP3) and Rab11, a small guanosine triphosphatase
(GTPase) implicated in membrane trafficking, in the secretion of TNF-α. LPS induces the
production of both VAMP3 and Rab11. Macrophages that overexpress VAMP3 or are
transfected with a constitutively active form of Rab11 show increased delivery of TNF-α to
the cell surface27. In contrast, the delivery of TNF-α to the cell surface, but not the synthesis
of TNF-α, is blocked in macrophages that express dominant-negative forms of VAMP3 or
Rab11. Furthermore, production of both VAMP3 and Rab11 is induced more quickly by
priming cells with IFN-γ. It is possible that IFN-β, when combined with KDO, induces a similar
synergistic increase in VAMP3 and Rab11 or some equivalent pathway.
The potentiation of secretion of IL-6 that resulted from the simultaneous stimulation of cells
with IFN-β, KDO, and ISO or 8Br indicates that these three pathways converge at least at one
site (Fig. 7). A similar potentiation in the secretion of IL-10 was not observed under the same
conditions (Fig. 3). This seems surprising because IL-6 induces the secretion of IL-10 in these
cells5 (Fig. 1). In the same experiments, potentiation of IL-10 was observed with the
combination of KDO and IL-6 and correlated with dual combinations of ligands that potentiate
secretion of IL-6, such as KDO paired with either IFN-β or 8Br (Fig. 3 and Fig. 9). The lack
of synergy at the first time point might be expected because the concentration of secreted IL-6
(about 100 pM) was insufficient to induce production of IL-10. In this case, the additive nature
of the triple response would suggest that the synergy in IL-10 production produced by the
combinations of KDO-IFN-β and the KDO-cAMP pathway stems from separate parallel
pathways. However, the amount of IL-6 secreted by the three combined ligands at longer times
of incubation exceeded the threshold for stimulating the secretion of IL-10. A potential
explanation for a lack of synergy could be that the IL-6 pathway is simply saturated by the
other ligands. Alternatively, the absence of potentiated amounts of IL-10 by the increased
quantities of extracellular IL-6 reflects the existence of an underlying inhibitory mechanism
in which IL-6 can also mediate attenuation of IL-10 secretion, which is synergized by other
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ligand pairs (Fig. 9). Such established mechanisms of cytokine regulation may include
suppressors of cytokine signaling (SOCS) proteins to inhibit signal transduction from the IL-6
receptor, the downregulation of functional IL-6 receptor itself, or the induction of a decoy
receptor antagonist in analogy to mechanisms that regulate IL-1 and IL-1028.
TGF-β inhibited the potentiation of IL-6 by KDO in combination with IFN-β, ISO or 8Br.
When combined with KDO and IFN-β, more prominent inhibition at later time points suggests
that TGF-β may act through a secondary mechanism, which potentially involves secretion of
an additional factor to mediate its suppressive effects. In general, the data presented here
demonstrate that TGF-β in this experimental paradigm inhibits cytokine secretion and has the
potential to reduce powerful stimulatory paradigms. The ability of TGF-β to inhibit is
consistent with its known immunosuppressive properties29, 30. However, IL-6 is also a
pleiotropic cytokine whose activities have been characterized as anti- and pro-
inflammatory31 and the ability of TGF-β to markedly modify its secretion in different venues
may produce the divergent effects.
The profiles of cytokine secretion reported here can be applied to well-studied paradigms as
well as novel areas where the roles of the cytokines are less defined. For example, the
interactions of IFN-β with signaling by TLR4 potentially play a role in defense against viruses.
The TLR family of receptors is one of two classes of receptors that can detect viruses within
a host organism11, 13, 14, 32, and type I IFNs such as IFN-β are necessary for viral clearance;
thus, mice devoid of the type I IFN receptors are highly susceptible to various viral
pathogens33–35. Pathways dependent on cAMP have been proposed to mediate aspects of
inflammation and fever through their mediation of TLR-dependent cytokines by prostaglandin
E2 (PGE2) receptors36, 37 or adenosine38 receptors, which couple to Gs, the stimulatory
heterotrimeric guanine nucleotide–binding protein (G protein) that activates adenylyl cyclase
and effects increases in the concentration of cAMP.
We have provided a systematic experimental paradigm to investigate the cytokine secretion
response by cells in response to stimulation by multiple ligands, a scenario likely to occur in
vivo. The higher-order responses uncovered in this study demonstrate both a rich diversity in
the interactions that are used to coordinate responses to multiplex stimuli as well as a high
degree of constraint in the number of pathway interactions that are realized. Thus, the context
in which various stimuli are detected by the cell leads to limited, but unique behaviors. The
limitation of unique responses suggests the biological importance of maintained crosstalk and
the interactions identified with this limited analysis of TLR4-dependent cytokine secretion in
macrophages. This systematic approach should be applicable to other systems and help identify
key interactions for regulating other cellular paradigms.
MATERIALS AND METHODS
Cell lines and tissue culture
Detailed information regarding the culture of RAW 264.7 cells can be obtained at
www.signaling-gateway.org, including the following Alliance for Cell Signaling (AfCS)
Protocols: Culture, PP00000159.1; preparation of frozen stocks, PP00000180; thaw protocol,
PP00000160. In brief, RAW 264.7 cells, a macrophage-like, Abelson leukemia virus–
transformed cell line derived from BALB/c mice, were obtained from the American Type
Culture Collection (ATCC; cat. no. TIB-71; lot no. 2263775). The thawed cells were expanded
by maintenance in RAW 264.7 growth medium 1 (RAWGM1) and passaged every two days
until sufficient cells were obtained for the preparation of frozen stocks. Numerous aliquots of
frozen cells from similar passages provided a uniform source of RAW 264.7 cells for
experimentation. Frozen aliquots of cells from the AfCS contain approximately 5 × 106 cells
in 1 ml of RAW 264.7 freezing medium [90% RAWGM1, 10% dimethyl sulfoxide (DMSO),
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PS00000568]. Stock vials of frozen AfCS cells were thawed and then maintained in RAWGM1
at 37°C in a humidified atmosphere with 5% CO2. For routine maintenance in culture (passage),
cells were seeded at a confluence of approximately 10% (1 × 106 and 3 × 106 cells in 100-mm
and 150-mm plates, respectively) and grown to approximately 80% confluency. This procedure
required the cells to be split every two days. For passage over the weekend, 3.3 × 105 and 7.5
× 105 cells are seeded in 100-mm and 150-mm dishes, respectively, to ensure no more than
80% confluence when harvested after three days. Cultures were not maintained beyond three
months.
Reagents
The following reagents were used to treat cells singly or in combination: 3-deoxy-D-manno-
octulosonic acid (KDO)2-Lipid A (a kind gift from Dr. H. A. Brown, Vanderbilt Univ.),
recombinant mouse IFN-β (Biosource International, PMC4024A), recombinant human IL-6
(Biosource International, PHC0064), isoproterenol hydrochloride (Sigma-Aldrich, I5627),
recombinant TGF-β1 (R & D Systems, 240-B), 8-Bromoadenosine 3′,5′-cyclic- AMP (Sigma-
Aldrich, B7880). Concentrations used to treat cells were as follows: KDO (10 ng/ml), IFN-β
(1 nM), hIL-6 (25 nM), ISO (50 nM), TGF-β1 (50 pM), and 8-Bromo cAMP (100 µM). The
dose chosen for each stimulation was approximately the EC50 for effects observed with single
ligands or in combination with LPS. This single dose provides a practical approach to maintain
experimentally manageable parameters and the likelihood of observing both positive and
negative effects potentially produced by other inputs. Human IL-6 was used to stimulate cells
to avoid interference with measuring secretion of mouse IL-6.
Cytokine measurements
Cells (2 ×105) were seeded into each well of a 24-well tissue culture plate and grown overnight
in 0.6 ml of RAWGM1 at 37°C and 5% CO2. After approximately 24 hours, the growth medium
was removed and replaced with 0.54ml of fresh, warm RAWGM1. Cells were returned to the
incubator for 1 hour while the ligands were prepared. Ligands were diluted in RAWGM1 and
added to the cells as 10X stocks (0.06 ml) for treatments. All treatments occurred in the presence
of serum, circumventing the need for LPS binding protein (LBP). Cells were then incubated
with ligands for the indicated times at 37°C in an atmosphere containing 5% CO2. Incubations
were terminated by harvesting the culture media and clarifying by centrifugation for 5 minutes
at 300g. Aliquots were prepared and frozen until ready for measurement of cytokines. G-CSF,
IL-6, IL-10, MIP-1α, RANES, and TNF-α were quantified with the Bio-Plex™ cytokine array
system (Bio-Rad Laboratories, Hercules, CA) with a custom-prepared mouse cytokine assay
kit for G-CSF, IL-6, IL-10, RANTES and individual kits for TNF-α (Bio-Rad, 171G12221)
and MIP1-α (Bio-Rad, X600004QE0).
Numerical analysis
The methods for the comparison of cytokine responses have been described previously5. In
brief, data were collected for each cytokine in mock-stimulated cells to provide a mean value
and variance with no applied stimulus. Each data variable collected upon ligand stimulation
was then expressed as the number of standard deviations removed from the error model so
obtained. Thus, for ligand i generating a value of ai for the experimental variable x, the
transformed representation of the value is given by
where  is the significance (in σ units) of observing ai given the error model. Multiple repeats
of applying ligand i produce a distribution of Z-scores for variable x; thus, the raw data variable
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is transformed into a mean Z-score with error. This approach provides a dimensionless unit of
significance for any particular response.
It is easy to estimate the interactions between any pair of ligands, and these methods have been
described extensively in prior work5. For instance, consider the case when any two ligands
(1,2) are applied. The observed response of any cytokine x to the combination of both ligands
applied  is compared to the expected effect if the two ligands act independently
, and the difference is used to identify the extent of interaction between the two ligands.
Because observations are made multiple times, the interaction observed is calculated as the
difference between the two, weighted for the propagated errors of measurement as
Note that the significance of response is critically dependent upon the error measurement;
therefore, care was exercised to remove systematic errors in measurement before these
calculations were made. As the individual errors of measurement in multiple ligand stimuli
can be collectively bundled into the expected sum of ligand responses, the mean area under
the curve for the expected trace was first calculated. A scaling factor equal to the ratio of a
given expected curve to the mean expected curve was calculated. Each single ligand and
pairwise treatment was divided by the scaling factor for its pair-matched expected curve. The
resultant dataset was used for generation of mean single ligand and observed combinatorial
responses and their respective standard deviations.
When higher-order combinations of ligands were used, the observed response to the
combination of n ligands  could be similarly decomposed into the individual responses
of each of the n ligands acting independently , all interactions of the two way combinations
within the n ligands, all interactions of the three way combinations within the n ligands, etc.
up to (n) combinations:
To illustrate, the secretion of cytokine x in response to three ligands is simply the effect of each
of the three ligands acting individually, the interactions between any two pairs of ligands, and
the interactions between all three ligands, and is instantiated as:
To identify the synergy induced by the three-way combination alone, we can simply
reconfigure the above as:
In other words, quantification of a synergy or anergy caused by a specific combination of n
ligands can be decomposed easily based on knowledge of experimentally observed responses
to all (n-1) combinations of ligands. Note that we do not have to calculate the contributions to
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nonadditivity (and correspondingly the error) at each level of ligand combination—such a
process can introduce bias in the error analysis. To further the visualization of these data, the
data within each experiment were scaled and represented on a colorimetric scale such as shown
in Fig. 2. Note that the color schemes within an experiment corresponded with absolute z-
values, but colors were relative across experiments.
Quantitative reverse transcriptase polymerase chain reaction assays
The abundance of mRNAs for G-CSF and MIP-1α in lysates of RAW cells was assessed by
real-time, quantitative reverse transcriptase PCR (qRT-PCR) with a Bio-Rad iCycler. Detailed
procedures for the assessment of mRNA by qRT-PCR have been described previously39. The
sequences of the sense and antisense amplification primers and the probes used were as follows.
G-CSF: 5’-CGTTCCCCTGGTCACTGTCA-3’; 5’-GGGTGACACAGCTTGTAGGTG-3’;
5’-TexasRed-CGCTCTGCCACCATCCCTGCCTCT-BHQ2-3’; MIP-1α: 5’-
CTCTGTCACCTGCTCAACATCA-3’; 5’-CTAGGAGACACCTGGTCATCTTG-3’; 5’-
TexasRed-AGGTCTCCACCACTGCCCTTGCTG-BHQ2-3’; β-actin (reference): 5’-
TCCATGAAATAAGTGGTTACAGGA-3’; 5’-CAGAAGCAATGCTGTCACCTT-3’; 5’-
HEX-TCCCTCACCCTCCCAAAAGCCACC-BHQ1-3’.
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Fig. 1.
Secretion of cytokines in response to single ligands. RAW 264.7 cells were treated with KDO
(black circle), IFN-β (green diamond), IL-6 (light-blue triangle), ISO (red square), 8Br-cAMP
(dark-blue hexagon), TGF-β (pink circle), or were left untreated (open inverted triangle) for
150, 195, or 240 minutes. The supernatants were removed, and the concentrations of IL-10,
IL-6, G-CSF, TNF-α, RANTES, and MIP-1α were measured (pg/ml). The normalized traces
[mean ± standard deviation (s.d.), n>10) are shown. For traces in which the lines overlap,
additional staggered symbols are shown for easy identification.
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Fig. 2.
Classification of interactions between ligands. Two ligands, L1 and L2, are capable of eliciting
cytokine secretion individually (A, solid black lines). When applied in combination, the two
ligands may act in any one of several ways: they may act independently of each other yielding
an additive response (dotted black line, surrounding white region); they could synergize to
yield a greater-than-additive response (red); they may inhibit each other to yield a response
lower than the individual responses (blue); they could elicit some intermediate response
between the responses of the individual ligands and that of the predicted additivity (yellow to
green). The last set of responses may be mechanistically generated by any one of several
processes, including saturation and noncompetitive antagonism, among others. (B) The
significance of nonadditivity can be calculated and displayed by this colorimetric scheme in a
heat map.
Hsueh et al. Page 17
Sci Signal. Author manuscript; available in PMC 2009 July 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 3.
Secretion of IL-10 in response to KDO, IFN-β, and IL-6. RAW 264.7 cells were treated with
single, double, or triple combinations of ligands. The results for each cytokine were normalized
and the statistical significance was determined as described in the Materials and Methods.
Examples of secretion of IL-10 are shown for the dual (A and B) and triple (D) combinations
of ligands. (C) Secretion of IL-6 can also be synergistically induced by the combination of
KDO with IFN-β. Panels A to C display the single ligand responses, the predicted response of
combinations of ligands (expected), and the observed values for combinations (observed).
Panel D shows only the predicted and observed values for the 3-way combinations. Statistical
significance for nonadditivity of the combinations is shown at the right.
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Fig. 4.
Secretion of MIP-1α in response to KDO, IFN-β, and IL-6. RAW 264.7 cells were treated with
single, double, or triple combinations of ligands and the secretion of MIP-1α was measured as
described. The results from multiple experiments were normalized and statistical significance
was determined as described in the Materials and Methods. Each panel shows the single ligand
responses and the observed and predicted (expected) responses for dual (A and B) and triple
(C) ligand combinations. The predicted response is based on the additive effects of the ligands;
the bar underneath the graphs quantitates the nonadditivity of the ligand combinations.
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Fig. 5.
Secretion of G-CSF in response to KDO, IFN-β, and ISO. The secretion of G-CSF (A and B)
by RAW 264.7 cells was measured in response to KDO, IFN-β, and either ISO or 8Br. (C) The
relative abundance of G-CSF mRNA was quantified by qRT-PCR. A single representative
experiment is shown. Error bars show the range between duplicate samples. All samples were
normalized to time-matched untreated samples. All columns except the responses to IFN-β
alone were significantly different from the untreated sample (p<0.05).
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Fig. 6.
Secretion of MIP-1α in response to KDO, IFN-β, and ISO. The secretion of MIP-1α by RAW
264.7 cells was measured in response to KDO, IFN-β, and either ISO (A) or 8Br (B). Results
are the average of 2 to 5 normalized experiments each containing duplicate samples. (C) The
relative abundance of G-CSF mRNA was quantified by qRT-PCR. A single representative
experiment is shown. Error bars show the range between duplicate samples. All samples were
normalized to time-matched untreated samples. All columns were statistically significantly
different from the untreated sample (p<0.05).
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Fig. 7.
Secretion of IL-6 in response to KDO, IFN-β, and ISO. The secretion of IL-6 by RAW 264.7
cells was measured in response to KDO, IFN-β, and ISO (A) or 8Br (B). The average of the
normalized values of 2 to 5 experiments, each with at least duplicate samples, are shown.
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Fig. 8.
Secretion of IL-6 in response to KDO, IFN-β, TGF-β, and the cAMP pathway. The secretion
of IL-6 by RAW 264.7 cells was measured after treatment of cells with KDO, IFN-β, TGF-β,
and either ISO or 8Br for the indicated times. The normalized values of 2 to 5 experiments
with samples prepared in at least duplicate were averaged and the errors determined.
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Fig. 9.
Quantified, synergistic cytokine responses to stimulation with multiple ligands. A summary
matrix of the cytokine responses in RAW 264.7 cells is shown for all treatments performed
with single, double, triple, quadruple, and quintuple combinations of ligands. The results for
each cytokine were normalized and the statistical significance was determined as described in
the Materials and Methods.
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